Concepedia

Mikael Franzon

MF

12

Publications

841

Citations

11

H-Index

1995

Active since

Affiliations

Pfizer (United States)(Current)

West Virginia University

University of Vermont

University of Arizona

National University Hospital of Iceland

Mikael Franzon is an author at Pfizer (United States) specializing in tobacco cessation, medicine, and tobacco control.

Top concepts

MedicinePublic HealthTobacco ControlSmoking CessationTobacco CessationAddictionVapingAllergySubstance AbuseAddiction Medicine

Publications per year

1995–2017

12

Publications

12

Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial

Nina Schneider, Richard Olmstead, Freny Vaghaiwalla Mody et al. · Addiction · 2003 · 124 citations

Tobacco Cessation, Nicotine Gum, Pharmacotherapy +16

Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial

Nina Schneider, Richard Olmstead, Fredrik Nilsson et al. · Addiction · 1996 · 122 citations

Tobacco Cessation, Asthma, Placebo-controlled Trial +17

Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial

Nina Schneider, Richard Olmstead, Fredrik Nilsson et al. · Addiction · 1996 · 105 citations

Tobacco Cessation, Tobacco Control, Nicotine Inhaler +10

Efficacy of a nicotine nasal spray in smoking cessation: a placebo-controlled, double-blind trial

Nina Schneider, Richard Olmstead, Freny Vaghaiwalla Mody et al. · Addiction · 1995 · 102 citations

Tobacco Cessation, Tobacco Control, Allergy +9

A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation

Thórarinn Blöndal, Mikael Franzon, Åke Westin · European Respiratory Journal · 1997 · 78 citations · Full text

Tobacco Cessation, Nicotine Nasal Solution, Pharmacotherapy +16

Rows per page

1–5 of 12